Human Genetics

Grants, Contracts, and Industry Agreements

Grant and Contract Awards	Annual Direct / Project Period Direct

DU, H

PPARgamma in the Lung
National Institutes of Health
R01 HL 087001	06/09/08 - 05/31/13	$250,000 / $1,250,000

GRABOWSKI, G

Cincinnati Regional Genetics Center
Ohio Department of Health
31-3-001-1GS0209	07/01/08 - 06/30/09	$383,500 / $383,500
Studies of Gaucher Disease
National Institutes of Health
R01 DK 036729	09/27/07 - 08/31/12	$276,902 / $1,449,180
Studies of Gaucher Disease
National Institutes of Health
R01 DK 036729 (supplement)	06/15/09 - 12/31/09	$5,000 / $5,000
Therapy of Neuronopathic Gaucher Disease
National Institutes of Health
R21 HD 059823	01/10/09 - 12/31/10	$100,000 / $275,000
Therapy of Gaucher Disease: In Vivo Enhancement
National Institutes of Health
R21 NS 064352	05/15/09 - 04/30/11	$126,883 / $275,000
Digestive Health Center: Bench to Bedside Research in Pediatric Digestive Disease
National Institutes of Health
104571	08/01/07 - 05/31/12	$21,243 / $106,215

GUAN, M

Nuclear Modifier Genes for Maternally Inherited Deafness
National Institutes of Health
R01 DC 007696	07/01/07 - 06/30/11	$209,738 / $850,000
Nuclear Modifier Genes for Maternally Inherited Deafness (Summer Supplement)
National Institutes of Health
R01 DC 007696	06/01/09 - 10/31/10	$10,000 / $10,000

KNAPKE, S

Hereditary Breast Cancer: BRCA and Beyond
Komen Breast Cancer Foundation
	04/01/09 - 03/31/10	$47,045 / $47,045

NEILSON, D

Genetic Mechanism of Acute Necrotizing Encaphalopathy
National Institutes of Health
K08 NS 050331	09/01/08 - 06/30/10	$156,412 / $250,954

PROWS, D.

Genetic Analysis of Hyperoxia-Induced Acute Lung Injury
National Institutes of Health
R01 HL 075562	05/01/09 - 04/30/13	$295,265 / $1,116,554

QI, X

SapC-DOPS Nanovesicles for Treating Glioblastoma Multiform
National Institutes of Health (Bexion Pharmaceuticals)
R43 CA 136017	09/25/08 - 06/24/09	$97,200 / $97,200
A Novel Biotherapeutic Treatment for Pancreatic Cancer
National Institutes of Health (Bexion Pharmaceuticals)
R43 CA 117283	09/25/08 - 06/24/09	$32,649 / $32,649

RUSCHMAN, J

Puberty and Cancer Initiation: Environment Diet and Obesity
National Institutes of Health (University of Cincinnati)
U01 ES 012770	08/01/08 - 07/31/10	$4,210 / $17,461

SCHORRY, E

Spinal Abnormalities in Neurofibromatosis Type 1
National Institutes of Health (University of Utah)
R01 NS 050509	07/01/06 - 03/31/11	$46,168 / $333,163
Neurofibromatosis Consortium Development Operation
Department of Defense - Army (University of Alabama at Birmingham)
W81XWH-05-1-0615	07/01/07 - 03/31/10	$24,754 / $104,791
Neurofibromatosis Consortium Development PK Center STOPN
Department of Defense - Army (University of Alabama at Birmingham)
W81XWH-05-1-0615	07/01/08 - 06/30/11	$67,840 / $271,360
Neurofibromatosis Consortium Development STOPn Protocol - Laboratory
Department of Defense - Army (University of Alabama at Birmingham)
W81XWH-05-1-0615	07/01/08 - 06/30/11	$66,283 / $265,132

LESLIE, N

Implementing Newborn Screening for Duchenne Muscular Dystrophy in the Community
National Institutes of Health
104471	09/01/07 - 08/31/10	$19,723 / $62,028

Current Year Direct	$2,240,815

Industry Contracts

Grabowski

Genzyme Corporation	$ 59,565
Shire Human Genetic Therapies	$ 413,608

Hopkin

$ 39,971

Leslie

Amicus Therapeutics, Inc.	$ 40,265
Genzyme Corporation	$ 40,425

Qi

$ 14,602

Current Year Direct Receipts	$548,871

Funded Collaborative Efforts

ZHANG, K

Macrophage Activation Syndrome Biomarkers in Systemic Juvenile Idiopathic Arthritis
National Institutes of Health
GROM, A	08/18/08 - 07/31/13	5 %

Total	2,789,686

Divisions

Human Genetics

Print This Page |

Email This Page